Annual General Meeting 2025

Annual General Meeting 2025

Merck KGaA, Darmstadt, Germany held its 30th Annual General Meeting virtually on April 25, 2025. All of the resolutions on the agenda were approved, including the proposed dividend of € 2.20 per share.

  • Presence & voting results

    Here you will find the presence and voting results 2025.

    Read more
  • Speech by the CEO

    Speech by Belén Garijo, Chair of the Executive Board and CEO.

    Read the speech

Documents for the annual general meeting of Merck KGaA, Darmstadt, Germany on April 25, 2025

    Download
  Convening Notice for the Annual General Meeting of Merck KGaA, Darmstadt, Germany, on 25 April 2025
PDF
  Speech by Belén Garijo, Chair of the Executive Board and CEO (Updated April 25, 2025. Check against delivery.) PDF
  Presence and Voting results PDF
  Dividend announcement PDF
  Information in accordance with Table 8 of the Regulation (EU) 2018/1212  PDF
  Sample of the agenda voting card PDF
  Document in accordance with Section 125 of the German Stock Corporation Act (AktG) in conjunction with Implementing Regulation (EU) 2018/1212 (GOR) PDF
  Explanation of Shareholder Rights PDF
  Technical Directions for the Investor Portal PDF
  Information on Data Privacy for Shareholders PDF
  Articles of association of Merck KGaA, Darmstadt, Germany PDF
  Annual report of Merck KGaA, Darmstadt, Germany for the fiscal year 2024 including the consolidated financial statements, combined Management report and Supervisory Board report PDF
  Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2024 including the combined Management report and Supervisory Board report PDF
  To agenda item 7: Compensation Report 2024 PDF
  To agenda item 8: Compensation System of the Executive Board of Merck KGaA, Darmstadt, Germany pursuant to section 87A(1) of the German Stock Corporation Act from 2026 PDF
  To agenda item 9: Statement on AGM Format PDF

Related News

View All News
  1. Press Releases

    Annual General Meeting Approves All Agenda Items 

    Our 30th Annual General Meeting approved all resolutions on the agenda, including the proposed dividend of € 2.20 per share, today.

    2025/04/25

Previous Annual General Meetings

Annual General Meeting Archive

Archived documents for the past annual general meetings

Read More

Frequently asked Questions about Investing in Merck KGaA, Darmstadt,Germany